Thyroid Gland Papillary Carcinoma

8 clinical trials · Condition

Record	Firm	Date
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial (NCT07529080)	University of Michigan Rogel Cancer Center	2026-07-01
Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors (NCT07545837)	Mayo Clinic	2026-06-23
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation (NCT06440850)	City of Hope Medical Center	2024-07-15
Radiofrequency Ablation for the Treatment of Benign or Low Risk Thyroid Nodule (NCT05003856)	M.D. Anderson Cancer Center	2022-08-29
Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer (NCT05575440)	Mayo Clinic	2022-04-22
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer (NCT04759911)	M.D. Anderson Cancer Center	2021-02-26
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer (NCT03914300)	National Cancer Institute (NCI)	2020-02-10
Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer (NCT03506048)	Emory University	2019-01-16

Every clearance here is in the API, with alerts when new ones post.